Night Blindness — Retinitis Pigmentosa

Night Blindness — Retinitis Pigmentosa

Retinitis Pigmentosa (night blindness), is a hereditary retinal eye disease affecting approximately one in 4,000 people. It is passed down through generations. The night blindness condition affects the retina, the light-sensitive nerve layer lining the back of the eye. It progresses slowly and causes definite vision loss in its later stages. It is also commonly known in Turkish as “tavuk karası“.

What causes night blindness?

In summary, Retinitis Pigmentosa, is part of a group of inherited eye diseases. All forms affect the retina’s ability to detect light. Factors relating to the retinal condition may include:

• How well you can tolerate particular medicines, procedures or therapies.
• How long treatment will last.
• Your opinion or preference.

In particular, Retinitis Pigmentosa symptoms can sometimes resemble those of other retinal diseases, so always consult an ophthalmologist for an accurate diagnosis.

Early Diagnosis and Treatment

Diagnosing night blindness may allow its progression to be stopped or slowed. Patients with this condition may receive sub-Tenon’s PRP (platelet-rich plasma) or Wharton’s jelly stem cell treatment. The aim is to slow or stop the progression of retinitis pigmentosa. PRP or Wharton’s jelly-derived mesenchymal stem cells are used for treatment.

In the early stages, treatment with Wharton’s jelly-derived mesenchymal stem cells for  night blindness — retinitis pigmentosa is considered an effective and safe option for slowing or stopping progression without adverse effects.

In particular, Retinitis Pigmentosa if you suspect you have this condition, we recommend booking an appointment with our retinal specialist ophthalmologist as soon as possible.

Dr. Hüseyin CENGİZ

Dr. Efsane H. CENGİZ

Dr. Ümit ATİK

Dr. Ali ÖZER

Dr. İdil GÖKSEL

Dr. Fatih BALTU

Dr. Ümit YAPICI

Click the useful links below: Who are our experienced specialist ophthalmologists? Everything You Need to Know About Cataract Surgery. About the Sensitive Profile Patient Programme. Everything You Need to Know About Glaucoma Treatments.